An ESICM Talk powered by the ICM Journal & the NEXT Committee The European Society of Intensive Care Medicine (ESICM), initiated a study to describe the extent of the COVID-19 ICU surge worldwide and the clinical characteristics, management, and outcomes of critically ill COVID-19 patients. Additionally, the goal was to study the impact of […]
MARCH 17, 2017
[…]
MARCH 17, 2017
[…]
An ESICM Talk powered by the ICM Journal & the NEXT Committee The prevalence of long-term mental health symptoms in the family members of COVID-19 ICU survivors is unknown and may differ from the prevalence rate in the family members of non-COVID-19 ICU survivors, given the pandemic circumstances. A better understanding of the impact […]
MARCH 17, 2017
[…]
ESICM Talk: Episode 3 Systemic corticosteroids decrease mortality in critically ill patients with COVID-19, and the World Health Organization, therefore, recommends dexamethasone 6 mg daily for up to 10 days for patients with severe or critical COVID-19. In addition, higher doses of systemic corticosteroids have been used in patients with COVID-19 and non-COVID-19 acute […]
